Quality is our legacy     
.
Site Language
.
.

.
 Search 
   Home
 
SEDICO Company
About SEDICO
News and Reports
Worldwide Presence
Careers at SEDICO
 
SEDICO products
Products List
Strategic Brands
Search for a product
 
Social Contribution
Diabetes Center
R&D
Caring for community
Access for medicines
 
Contact SEDICO
Contact Us
Distributors Log in
Partners Log in
Vendors Log in
Physicians Log in
Patients Log in
 
SEDICO Newsletter
Subscribe to SEDICO News

   Enter Your E-mail
 

Physician
Patient

Diabride ( Tablets )


Diabride tablets

Composition:

Each tablet contains:
Glimepiride...................1mg, 2mg or 3mg.

Prescribing information :

Glimepiride  is an oral hypoglycemic drug of the Sulfonylurea class. It lowers blood glucose levels by stimulating the release of insulin from functioning pancreatic beta cells & also by increasing the sensitivity of peripheral tissues to insulin.
Diabride is totally absorbed from the GIT within 1 hour, with peak drug levels at 2 - 3 hours


Indications: 


Non insulin dependent diabetes mellitus ( NIDDM) not responding to diet & exercise alone.
In combination with insulin in patients whose glucose levels cannot be controlled by diet, exercise, & oral hypoglycemic agents alone.


Contraindications :


Hypersensitivity to the drug
Diabetic ketoacidosis, with or without comma.


Precautions:


Hypoglycemia : All sulfonylureas are capable of producing hypoglycemia, proper patient selection, dosage & instructions are important .
Loss of control of blood glucose, when a patient is exposed to stress as fever, trauma, infection, or surgery , loss of control of blood glucose may occur. It should be necessary to add insulin to Diabride or even use insulin monotherapy.


Use during pregnancy & Lactation :

Diabride should not be used during pregnancy as it may cause congenital abnormalities. It is also not recommended to use during lactation. It is advised that insulin be used during pregnancy & lactation to maintain glucose levels as close to normal as possible.


Adverse Effects:

Nausea, vomiting, gastrointestinal pain,& diarrhea have been rarely reported.
Dizziness, pruritus, erythema & urticariaoccur in less than 1 % .


Dosage :

starting dose ..............................1 to 2 mg once daily.
Maintenance dosage ...................1 to 4 mg once daily.
After reaching a dose of 2 mg, the dose should increase no more than 2 mg at 1 - 2 week intervals based upon the patients glucose response. The maximum recommended dose is 8 mg daily.


storage :

Keep at temp not exceeding 30 °C


Presentation :

Box of 10 tablets ( 2mg )
Box of 10 tablets ( 3mg )



Insulin bio NPH
Insulin Biomix
Insulin Bio R

 


© 2004 Sedico Co. All rights reserved
Designed and Developed by EBM Co.